Madrigal Pharmaceuticals appoints Michael Charlton as SVP, clinical development

Madrigal Pharmaceuticals announced the appointment of Michael R. Charlton, M.B.B.S., F.R.C.P., as Senior Vice President, Clinical Development, effective October 1, 2024. Charlton has more than thirty years of leadership experience in hepatology, gastroenterology, and liver transplantation, with a particular expertise in NASH. He has held academic leadership roles at the Mayo Clinic, where he served as Director of Hepatology, the University of Chicago and Intermountain Medical Center. As Medical Director of the Transplant Institute at the University of Chicago, Dr. Charlton spearheaded innovative clinical programs targeting NASH and other liver disease